Sareum Holdings discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. The Company's drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate. Sareum Holdings develops therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The Company’s product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, TYK2 kinase-autoimmune diseases and TYK2 kinase-cancer.
|Employees (est.) (Aug 2017)||2|
Sareum Holdings has 904 Twitter Followers. The number of followers has decreased 0.1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Sareum Holdings founded?
Sareum Holdings was founded in 2003.
How many employees does Sareum Holdings have?
Sareum Holdings has 2 employees.
Who are Sareum Holdings competitors?
Competitors of Sareum Holdings include Innocare, MolMed and Cleave Biosciences.
Where is Sareum Holdings headquarters?
Sareum Holdings headquarters is located at 2a Langford Arch London Rd, Pampisford.
Where are Sareum Holdings offices?
Sareum Holdings has an office in Pampisford.
How many offices does Sareum Holdings have?
Sareum Holdings has 1 office.
Receive alerts for 300+ data fields across thousands of companies